HK1203841A1 - Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol - Google Patents
Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanolInfo
- Publication number
- HK1203841A1 HK1203841A1 HK15104636.5A HK15104636A HK1203841A1 HK 1203841 A1 HK1203841 A1 HK 1203841A1 HK 15104636 A HK15104636 A HK 15104636A HK 1203841 A1 HK1203841 A1 HK 1203841A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ethanol
- influence
- resistance against
- nutraceutical composition
- resistant pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3531CH2012 | 2012-08-27 | ||
| PCT/EP2012/070639 WO2014032741A1 (fr) | 2012-08-27 | 2012-10-18 | Composition pharmaceutique ou nutraceutique gastrorésistante présentant de la résistance vis-à-vis de l'influence de l'éthanol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1203841A1 true HK1203841A1 (en) | 2015-11-06 |
Family
ID=54203595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15104636.5A HK1203841A1 (en) | 2012-08-27 | 2015-05-15 | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10639283B2 (fr) |
| EP (1) | EP2887925B1 (fr) |
| JP (1) | JP6150896B2 (fr) |
| KR (1) | KR20150047493A (fr) |
| CN (1) | CN104507460A (fr) |
| AU (1) | AU2012388440B2 (fr) |
| BR (1) | BR112015001371A8 (fr) |
| CA (1) | CA2877502C (fr) |
| ES (1) | ES2625017T3 (fr) |
| HK (1) | HK1203841A1 (fr) |
| HU (1) | HUE031818T2 (fr) |
| IL (1) | IL236313B (fr) |
| MX (1) | MX355662B (fr) |
| PL (1) | PL2887925T3 (fr) |
| RU (1) | RU2015110825A (fr) |
| SI (1) | SI2887925T1 (fr) |
| WO (1) | WO2014032741A1 (fr) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| AR077420A1 (es) | 2009-07-22 | 2011-08-24 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion para opiaceos sensibles a la oxidacion |
| ES2486791T3 (es) | 2010-09-02 | 2014-08-19 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación que comprende una sal inorgánica |
| LT2736495T (lt) | 2011-07-29 | 2017-11-10 | Grünenthal GmbH | Sugadinimui atspari tabletė, pasižyminti greitu vaisto atpalaidavimu |
| RS56527B1 (sr) | 2011-07-29 | 2018-02-28 | Gruenenthal Gmbh | Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu |
| EP2838512B1 (fr) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Forme pharmaceutique inviolable et résistante au basculement de dose |
| AU2012388441B2 (en) | 2012-08-27 | 2017-07-27 | Evonik Operations Gmbh | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
| MX368846B (es) | 2013-07-12 | 2019-10-18 | Gruenenthal Gmbh | Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo. |
| EP3073994A1 (fr) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Préparation de composition pharmaceutique en poudre par cryo-broyage |
| WO2016035756A1 (fr) * | 2014-09-03 | 2016-03-10 | ライオン株式会社 | Préparation enrobée et son procédé de production |
| WO2016046817A1 (fr) * | 2014-09-24 | 2016-03-31 | Vital Beverages Global Inc. | Compositions et procédés pour libération sélective dans le tractus gastro-intestinal |
| EP3288556A4 (fr) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Compositions à désintégration par voie orale |
| JP6824197B2 (ja) | 2015-06-05 | 2021-02-03 | エボニック オペレーションズ ゲーエムベーハー | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
| US20170296476A1 (en) * | 2016-04-15 | 2017-10-19 | Grünenthal GmbH | Modified release abuse deterrent dosage forms |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| US20180369151A1 (en) | 2017-05-29 | 2018-12-27 | Grünenthal GmbH | Multiparticulate oral dosage form providing prolonged release of tapentadol |
| JP7050148B2 (ja) * | 2017-08-15 | 2022-04-07 | エボニック オペレーションズ ゲーエムベーハー | オメガ－３脂肪酸アミノ酸塩の有効成分含有量が高い錠剤 |
| SG11202005947RA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
| AU2019275409A1 (en) | 2018-05-24 | 2020-07-16 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| EP3962465A1 (fr) * | 2019-04-30 | 2022-03-09 | Evonik Operations GmbH | Microgranule et système à unités multiples de microgranules (mups) |
| EP4009815A4 (fr) | 2019-09-12 | 2023-09-06 | Nulixir Inc. | Particules noyau-enveloppe à libération contrôlée et suspensions les comprenant |
| CN116096352A (zh) * | 2020-06-10 | 2023-05-09 | 阿帕亚知识产权公司 | 含有与胶凝剂组合的多个剂型的肠因子释放物质的药物组合物 |
| WO2022090112A1 (fr) * | 2020-10-29 | 2022-05-05 | Dsm Ip Assets B.V. | Kit spécifique comprenant une formulation de vitamine liposoluble spécifique et une formulation d'oligosaccharides de lait humain spécifiques |
| EP4176874A1 (fr) | 2021-11-09 | 2023-05-10 | Evonik Operations GmbH | Composition pharmaceutique ou nutraceutique dotée d'un système de revêtement monocouche résistant à l'alcool |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2135073C3 (de) | 1971-07-14 | 1974-07-11 | Roehm Gmbh | Überzugsmittel für Arzneiformen |
| DE9414065U1 (de) | 1994-08-31 | 1994-11-03 | Roehm Gmbh | Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen |
| DE9414066U1 (de) | 1994-08-31 | 1994-11-03 | Roehm Gmbh | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
| KR100387245B1 (ko) * | 1997-10-17 | 2003-08-19 | 일양약품주식회사 | 유산균의안정화를위한미세장용성코팅과립 |
| DE10011447A1 (de) | 2000-03-10 | 2001-09-20 | Roehm Gmbh | Dispersion mit nichtionischem Emulgator |
| GB0320020D0 (en) * | 2003-08-27 | 2003-10-01 | Mw Encap Ltd | Improved formulation for providing an enteric coating material |
| DE102004011349A1 (de) | 2004-03-05 | 2005-09-22 | Basf Ag | Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten |
| TW200533391A (en) | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
| US20090196889A1 (en) * | 2004-11-22 | 2009-08-06 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
| US20070104789A1 (en) | 2005-11-04 | 2007-05-10 | Donald Spector | Gastro-resistant and ethanol-resistant controlled-release formulations comprising hydromorphone |
| CA2680680A1 (fr) | 2007-03-29 | 2009-02-19 | Panacea Biotec Limited | Formes pharmaceutiques modifiees de tacrolimus |
| DE102007026037A1 (de) | 2007-06-04 | 2008-12-11 | Lts Lohmann Therapie-Systeme Ag | Gastroretentives System mit Alginat-Körper |
| MX357919B (es) * | 2009-03-13 | 2018-07-25 | Nucitec Sa De Cv | Composición farmacéutica para el tratamiento de la hipercolesterolemia. |
| JP5705319B2 (ja) * | 2010-08-18 | 2015-04-22 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングＥｖｏｎｉｋ Ｒｏｅｈｍ ＧｍｂＨ | １種以上のアルギン酸の塩を含む胃液抵抗性の医薬又は栄養補助製剤 |
| EP2420222B1 (fr) | 2010-08-19 | 2016-12-14 | Eckart GmbH | Vernis à ongle doté d'un toucher velours |
| BR112013014044A2 (pt) | 2010-12-06 | 2017-10-31 | Degama Barrier Ltd | composição, produto alimentício e processo para prepará-lo |
| AU2012388441B2 (en) | 2012-08-27 | 2017-07-27 | Evonik Operations Gmbh | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol |
-
2012
- 2012-10-18 AU AU2012388440A patent/AU2012388440B2/en not_active Ceased
- 2012-10-18 RU RU2015110825A patent/RU2015110825A/ru unknown
- 2012-10-18 EP EP12775668.2A patent/EP2887925B1/fr active Active
- 2012-10-18 JP JP2015528887A patent/JP6150896B2/ja not_active Expired - Fee Related
- 2012-10-18 HU HUE12775668A patent/HUE031818T2/en unknown
- 2012-10-18 CN CN201280074955.0A patent/CN104507460A/zh active Pending
- 2012-10-18 PL PL12775668T patent/PL2887925T3/pl unknown
- 2012-10-18 SI SI201230943A patent/SI2887925T1/sl unknown
- 2012-10-18 MX MX2015002583A patent/MX355662B/es active IP Right Grant
- 2012-10-18 CA CA2877502A patent/CA2877502C/fr active Active
- 2012-10-18 ES ES12775668.2T patent/ES2625017T3/es active Active
- 2012-10-18 KR KR1020157004618A patent/KR20150047493A/ko not_active Application Discontinuation
- 2012-10-18 BR BR112015001371A patent/BR112015001371A8/pt not_active Application Discontinuation
- 2012-10-18 WO PCT/EP2012/070639 patent/WO2014032741A1/fr active Application Filing
- 2012-10-18 US US14/416,500 patent/US10639283B2/en not_active Expired - Fee Related
-
2014
- 2014-12-17 IL IL236313A patent/IL236313B/en active IP Right Grant
-
2015
- 2015-05-15 HK HK15104636.5A patent/HK1203841A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015001371A8 (pt) | 2022-07-05 |
| MX2015002583A (es) | 2015-06-22 |
| US10639283B2 (en) | 2020-05-05 |
| AU2012388440B2 (en) | 2017-08-31 |
| EP2887925B1 (fr) | 2017-02-22 |
| SI2887925T1 (sl) | 2017-06-30 |
| BR112015001371A2 (pt) | 2017-07-04 |
| AU2012388440A1 (en) | 2015-01-22 |
| EP2887925A1 (fr) | 2015-07-01 |
| JP6150896B2 (ja) | 2017-06-21 |
| US20150209298A1 (en) | 2015-07-30 |
| PL2887925T3 (pl) | 2017-07-31 |
| IL236313A0 (en) | 2015-02-26 |
| CA2877502C (fr) | 2019-07-30 |
| CA2877502A1 (fr) | 2014-03-06 |
| ES2625017T3 (es) | 2017-07-18 |
| KR20150047493A (ko) | 2015-05-04 |
| MX355662B (es) | 2018-04-25 |
| HUE031818T2 (en) | 2017-08-28 |
| WO2014032741A1 (fr) | 2014-03-06 |
| CN104507460A (zh) | 2015-04-08 |
| RU2015110825A (ru) | 2016-10-20 |
| IL236313B (en) | 2020-03-31 |
| JP2015528450A (ja) | 2015-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203841A1 (en) | Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol | |
| HK1207822A1 (en) | Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol | |
| IL228396A0 (en) | A stomach-resistant pharmaceutical preparation or dietary supplement with resistance to the effect of ethanol | |
| HK1205690A1 (en) | Pharmaceutical composition and administration thereof | |
| IL251626A0 (en) | A pharmaceutical preparation or food additive with resistance to the effect of ethanol | |
| HK1244699A1 (zh) | 耐乙醇影響的藥物或保健品組合物 | |
| ZA201501930B (en) | Pharmaceutical composition | |
| HK1191572A1 (en) | Coating composition suitable for pharmaceutical or nutraceutical dosage forms | |
| IL228397A0 (en) | A coating preparation suitable for dosage forms of pharmaceuticals or nutritional supplements | |
| EP2832730A4 (fr) | Composition pharmaceutique contenant du mirabegron | |
| HK1225633A1 (zh) | 具有持續釋放特性並針對乙醇的影響具有抗性的藥物或營養組合物 | |
| GB2504390B (en) | Nutraceutical and pharmaceutical composition | |
| HK1219691A1 (zh) | 醫藥組成物及其用途 | |
| SI2538955T1 (sl) | Farmacevtska ali nutracevtska formulacija | |
| HK1220143A1 (zh) | 藥物組合物 | |
| ZA201502987B (en) | Pharmaceutical composition | |
| EP2897590A4 (fr) | Composition pharmaceutique | |
| PL2720683T3 (pl) | Odporne żołądkowo kompozycje farmaceutyczne lub nutraceutyczne z odpornością na wpływ etanolu | |
| EP2851078A4 (fr) | Composition pharmaceutique | |
| ZA201400751B (en) | Pharmaceutical composition | |
| GB201208978D0 (en) | Overcoming drug resistance |